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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
07.05.2020 COVID-19: 
PCR screening 
of 
asymptomatic 
healthcare 
workers at 
London hospital 
The Lancet | 
Correspondence 
 Understanding the determinants of 
asymptomatic infection could 
identify correlates of protection 
 This study reports serial testing in 
high-exposure asymptomatic 
HCWs 
 Data from this study suggests that 
the rate of asymptomatic infection 
among HCWs more likely reflects 
general community transmission 
than in-hospital exposure in a 
London setting 
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lnfection prevention and control 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
06.05.2020 Infection 
prevention 
and control 
compliance in 
Tanzanian 
outpatient 
facilities: a 
cross-
sectional 
study with 
implications 
for the control 
of COVID-19 
The Lancet 
Global Health | 
Article 
 This secondary analysis of cross-
sectional data collected in 2018 as 
part of a randomised controlled trial 
in 220 private for-profit dispensaries 
and health centres and in faith-based 
dispensaries, health centres, and 
hospitals in 18 regions of Tanzania 
identified health worker infection 
prevention and control compliance, 
especially for hand hygiene and 
disinfection, was inadequate in these 
outpatient settings 
 Improvements in supplies and 
compliance with IPC practices are 
urgently needed to contain rather 
than fuel COVID-19 transmission 
Epidemiology and modelling 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
06.05.2020 COVID-19 
on the 
African 
continent 
The Lancet 
Infectious 
Diseases | 
Correspondence 
 Illustrating the potential burden of 
SARS-CoV-2 epidemics within the 
most vulnerable countries in Africa, 
this study simulated a SARS-CoV-2 
outbreak in DR Congo in the absence 
of interventions using an age-
structured epidemiological model and 
assuming a basic reproductive 
number of 2.72 
 76,213,155 infections and 319, 441 
deaths were estimated in the 
absence of physical distancing (see 
figure) 
 Assessing the true burden of COVID-
19 and implementing effective case 
isolation is challenging where testing 
is sparse – by mid-April 
approximately 200 tests per day were 
being conducted in in DR Congo, 300 
tests per day in Senegal and 400 
tests per day in Ethiopia 
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Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Summary 
05.05.2020 Community-based 
health care, 
including outreach 
and campaigns, in 
the context of the 
COVID-19 
pandemic 
WHO & 
UNICEF | 
Interim 
Guidance 
 Discusses the specific role of 
community-based healthcare in 
the pandemic context and outlines 
adaptations needed to keep 
people safe, maintain continuity of 
essential services and ensure an 
effective response to C19 
May 2020 COVID-19: What 
are prisons a 
particular risk, and 
what can be done to 
mitigate this? 
SSHAP | Brief 
 Includes practical considerations 
to mitigate risks associated with an 
outbreak of C19 in prisons in 
LMICs 
April 2020 Considerations and 
principles for 
shielding people at 
high risk of severe 
outcomes from 
COVID-19 
SSHAP | Brief 
 Considers the rationale for 
shielding individuals at high risk of 
severe disease or death from C19 
in LMICs 
 Provides overview of approaches 
to shielding, including who to 
shield, and the likely challenges 
and ways to mitigate these 
challengeslancet 
05.05.2020 LSHTM COVID-19 
Transmission 
Model (version 1) 
CMMID 
Repository 
 Simulate C19 epidemics in 152 
countries, and see how school 
closures, social distancing, elderly 
shielding, self-isolation and 
lockdowns may impact cases, 
hospitalisations and deaths. 
Designed for educational 
purposes not medical or policy 
advice. 
04.05.2020 Community 
participation is 
crucial in a 
pandemic 
The Lancet | 
Comment 
 Includes a panel of steps to 
community participation in the C19 
response 
01.05.2020 Statement on the 
third meeting of the 
International Health 
Regulations (2005) 
Emergency 
Committee 
WHO | 
Statement 
 Statement from the third meeting 
(teleconference) of the expanded 
Emergency Committee on 30 April 
2020 convened by the WHO DG 
under the IHR (2005) regarding 
CoVID-19 
4 
regarding the 
outbreak of 
coronavirus 
disease (COVID-
19) 
30.04.2020 COVID-19 and the 
Rights of Persons 
with Disabilities: 
Guidance 
UN Human 
Rights 
  
28.04.2020 COVI-PREG CHUV 
 International COVID-19 and 
Pregnancy   Registry 
28.04.2020 Accessibility 
Campaign – 
COVID-19 
International 
Disability 
Alliance 
 Call for PH information and 
communications around COVID-
19 to be fully accessible 
24.04.2020 Handwashing 
compendium for low 
resource settings: a 
living document 
(edition 1) 
IDS Sanitation 
Learning Hub 
  
23.04.2020 Practical 
recommendations 
for the management 
of diabetes in 
patients with 
COVID-19 
The Lancet 
Diabetes & 
Endocrinology 
| Personal view 
 Practical recommendations for the 
management of diabetes in 
patients with C19, authored by an 
internal panel of experts in the 
fields of diabetes and 
endocrinology 
Ongoing WHO Country & 
Technical Guidance 
WHO   
Ongoing Rapid guidelines 
and evidence 
summaries 
NICE   
Ongoing Inter-Agency 
Standing 
Committee (IASC) 
IASC   
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Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article 
type 
Author(s) 
07.05.2020 Leave no one behind: using a 
benefit-based advance 
market commitment to 
incentivise development and 
global supply of COVID-19 
vaccines 
Center for Global 
Development | 
Notes 
Kalipso Chalkidou et al. 
06.05.2020 Health system quality in the 
time of COVID-19 
The Lancet Global 
Health | Comment 
Sanam Roder-DeWan 
06.05.2020 COVID-19 in Cameroon: a 
crucial equation to resolve  
The Lancet 
Infectious Diseases 
| Correspondence 
Francois-Xavier Mbopi-
Keou, Jean-Emmanuel 
Pondi & Maurice Aurelien 
Sosso 
06.05.2020 The immune system of 
children: the key to 
understanding SARS-CoV-2 
susceptibility?  
The Lancet Child & 
Adolescent Health | 
Comment 
Rita Carsetti et al. 
06.05.2020 COVID-19-associated 
nephritis: early warning for 
disease severity and 
complications? 
The Lancet | 
Correspondence 
Oliver Gross et al. 
06.05.2020 COVID-19: underlying 
metabolic health in the 
spotlight 
The Lancet 
Diabetes & 
Endocrinology | 
Editorial 
Jagdish Khubchandani, 
Timothy R Jorfan & Y Tony 
Yang 
06.05.2020 Effective transmission across 
the globe: the role of climate 
in COVID-19 mitigation 
strategies 
The Lancet 
Planetary Health | 
Correspondence 
Kathleen M O’ Reilly et al. 
05.05.2020 COVID-19: Shining the light 
on Africa 
Am J Trop Med 
Hyg | Editorial 
Philip J. Rosenthal et al. 
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30.04.2020 COVID-19 in fragile settings: 
Ensuring a conflict sensitive 
response 
World Bank | Blog Franck Bousquet & Oscar 
Fernandez-Taranco 
06.05.2020 Interpreting diagnostic tests 
for SARS-CoV-2 
JAMA | Viewpoint  Nandini Sethuraman et al. 
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence 
& policy 
maps 
Current 
research 
including 
trials 
  Diagnosti
cs 
  Treatmen
ts 
  Vaccin
es 
WHO 
sitreps 
WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-
CoV-2 Test 
Tracker 
  Global 
COVID-19 
Clinical 
Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Argumen
ts 
Indonesi
a 
EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-
CoV-2 
Diagnostics
: 
performanc
e data 
  US NIH 
registered 
clinical 
trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
Europea
n CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based tests 
for COVID-
19 
  Solidarity 
trial 
  
WEF 
  Sierra 
Leone 
 Oxford 
C19 
Governme
nt 
Response 
Tracker 
(OxCGRT) 
US NIH     COVID-
19 
Therapeuti
cs 
Accelerator 
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Our World 
in Data 
  Singapor
e 
  COVID-
evidence 
      
Global 
5050 
  UK   Cochrane       
CEBM, 
University 
of Oxford 
  US   Clinicaltrials.g
ov 
      
Humanitari
an Data 
Exchange 
       UKCDR       
Information 
is Beautiful 
              
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
              
C19 Resource Hubs 
Global  Region
al & 
Countr
y 
Academi
c 
journals 
& 
Publishe
rs 
Global Health 
Institutes/Centres/Funders/
Other 
Health 
Topics 
  Social 
Sciences 
WHO 
COVID-19 
pandemic  
Africa 
CDC 
The 
Lancet 
LSTM Stop TB 
Partnership 
  SSHAP 
8 
WHO risk 
communicati
on 
African 
Union 
NEJM LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Elsevier ICL MRC Centre for Global 
Infectious Disease Analysis  
Global 
Menstrual 
Collective  
  Disability 
and 
inclusion 
WHO Global 
research 
GeoPoll
: SSA 
BMJ ODI SLH: 
Handwashi
ng in low 
resource 
settings 
  Coregrou
p IDDC 
COVID-19 
Solidarity 
Response 
Fund 
Global 
Health 
Networ
k Africa 
Cell 
Press 
Johns Hopkins University 
 
  Rings 
HSG 
Resyst 
Reach 
Wellcome 
UN African 
Acade
my of 
Science
s 
Cochran
e 
resource
s 
Center for Global 
Development 
    Social 
Developme
nt Direct 
C19 blog 
series 
UN Women Africa 
Evidenc
e 
Networ
k 
PLoS CMMID Repository     
UNOCHA   Annals of 
Internal 
Medicine 
Norwegian Institute of Public 
Health 
    
UNHCR     Oxford Centre for Evidence-
based Medicine 
    
UNICEF      HEART     
UNESCO   Wiley 
Health 
 UKRI     
9 
Economi
cs 
UN WFP   Pre-
prints 
medRxiv 
and 
bioRxiv 
 Evidence Aid     
GOARN           
EPI-WIN           
World Bank           
COVID-19 
Narratives by 
David 
Nabarro 
          
Reliefweb           
Humanitarian 
OpenStreetM
ap Team 
          
Global 
Partnership 
for 
Sustainable 
Development 
Data 
          
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
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Global 
Impact Study 
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online learning 3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online learning Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel 
Coronavirus 
Online learning 3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
11 
20 April 
2020 
COVID-19 
Diagnostics and 
Testing 
Online learning 3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online learning 5 weeks | 1 
hour 
weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online learning Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
12 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
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